| Thu, 8 Oct 2026 | Reed Joshua | officer: SVP, Chief Financial Officer | F-InKind | 4,069 | $163.21K |
| Thu, 8 Oct 2026 | Reed Joshua | officer: SVP, Chief Financial Officer | M-Exempt | 9,164 | — |
| Fri, 2 Oct 2026 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 | $83.46K |
| Thu, 3 Sep 2026 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 | $97.65K |
| Tue, 1 Sep 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5,000 | $122.95K |
| Tue, 1 Sep 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 9,000 | $422.87K |
| Mon, 17 Aug 2026 | Nichols Christian Todd | officer: SVP, Chief Commercial Officer | S-Sale | 6,912 | $339.97K |
| Mon, 17 Aug 2026 | Nichols Christian Todd | officer: SVP, Chief Commercial Officer | S-Sale | 6,912 | $339.97K |
| Mon, 17 Aug 2026 | Nichols Christian Todd | officer: SVP, Chief Commercial Officer | S-Sale | 664 | $32.97K |
| Mon, 17 Aug 2026 | Nichols Christian Todd | officer: SVP, Chief Commercial Officer | S-Sale | 664 | $32.97K |
| Wed, 5 Aug 2026 | Jackson Blair Curtis | director, officer: President & CEO, Alkermes plc | A-Award | 93,229 | $4.63M |
| Wed, 5 Aug 2026 | Jackson Blair Curtis | director, officer: President & CEO, Alkermes plc | A-Award | 124,305 | $6.17M |
| Mon, 3 Aug 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 4,896 | $120.39K |
| Mon, 3 Aug 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 9,000 | $437.22K |
| Mon, 3 Aug 2026 | snyderman nancy lynn MD | director | M-Exempt | 27,948 | $1.31M |
| Mon, 3 Aug 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 104 | $2.01K |
| Mon, 3 Aug 2026 | snyderman nancy lynn MD | director | M-Exempt | 16,524 | $772K |
| Mon, 3 Aug 2026 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 | $98.81K |
| Mon, 3 Aug 2026 | snyderman nancy lynn MD | director | S-Sale | 44,472 | $2.24M |
| Mon, 6 Jul 2026 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 | $109.9K |
| Wed, 1 Jul 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 700 | $36.49K |
| Wed, 1 Jul 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5,000 | $96.7K |
| Wed, 1 Jul 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 8,300 | $427.13K |
| Fri, 12 Jun 2026 | Wright Christopher I | director | S-Sale | 2,000 | $90.2K |
| Thu, 4 Jun 2026 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 | $87.56K |
| Mon, 1 Jun 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 9,000 | $375.03K |
| Mon, 1 Jun 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5,000 | $96.7K |
| Fri, 29 May 2026 | Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | S-Sale | 16,217 | $686.95K |
| Fri, 29 May 2026 | Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 12,825 | $248.04K |
| Fri, 29 May 2026 | Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 3,392 | $67.94K |
| Thu, 21 May 2026 | Wilson Frank Anders | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | Wright Christopher I | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | MCKEON BRIAN P | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | snyderman nancy lynn MD | director | F-InKind | 1,475 | $54.5K |
| Thu, 21 May 2026 | snyderman nancy lynn MD | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | Cooke Shane | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | MCKEON BRIAN P | director | F-InKind | 1,475 | $54.5K |
| Thu, 21 May 2026 | Lurker Nancy | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | Lurker Nancy | director | F-InKind | 1,475 | $54.5K |
| Thu, 21 May 2026 | LAURENCIN CATO T | director | F-InKind | 1,475 | $54.5K |
| Thu, 21 May 2026 | LAURENCIN CATO T | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | Wilson Frank Anders | director | F-InKind | 1,475 | $54.5K |
| Thu, 21 May 2026 | GAYNOR RICHARD | director | M-Exempt | 6,142 | — |
| Thu, 21 May 2026 | GAYNOR RICHARD | director | F-InKind | 1,475 | $54.5K |
| Thu, 21 May 2026 | Cooke Shane | director | F-InKind | 3,207 | $118.5K |
| Thu, 21 May 2026 | Wright Christopher I | director | F-InKind | 1,475 | $54.5K |
| Mon, 4 May 2026 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 | $67.53K |
| Fri, 1 May 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5,000 | $96.7K |
| Fri, 1 May 2026 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 9,000 | $300.6K |
| Sat, 11 Apr 2026 | Lurker Nancy | director | F-InKind | 901 | $30.06K |
